Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
23.44
+0.05 (0.21%)
May 28, 2026, 2:34 PM EDT - Market open

Ultragenyx Pharmaceutical Revenue by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
366.81M369.31M339.18M321.49M314.47M285.47M265.30M230.30M
Product Growth
16.64%29.37%27.85%39.59%58.26%58.24%68.34%55.82%
Other
302.62M303.42M291.43M288.69M276.21M274.71M257.40M250.90M
Other Growth
9.56%10.45%13.22%15.06%13.29%8.24%1.90%2.37%

Revenue by Geography

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
378.21M377.00M361.22M354.58M340.56M340.46M316.40M307.30M
North America Growth
11.06%10.73%14.16%15.39%14.40%10.86%5.82%3.05%
Latin America
157.11M170.00M149.83M144.47M150.40M130.71M130.30M109.50M
Latin America Growth
4.46%30.06%14.99%31.93%67.67%69.10%93.32%70.30%
Europe
115.67M108.00M103.33M97.65M87.45M80.12M69.60M60.40M
Europe Growth
32.27%34.79%48.47%61.68%61.35%68.33%63.00%58.53%
Japan
18.72M18.00M12.64M9.79M8.69M5.40M6.40M4.10M
Japan Growth
115.49%233.33%97.48%138.66%768.50%145.45%433.33%70.83%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.